Literature DB >> 18808325

A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors.

Michelina Iacovino1, Carmen Hernandez, Zhaohui Xu, Gagan Bajwa, Melissa Prather, Michael Kyba.   

Abstract

Regulatory circuits that control stem cell fate decisions can be identified and understood by manipulating individual regulatory elements genetically. While impractical in the rare somatic stem cells of primary tissue, this approach is feasible in embryonic stem cells differentiated in vitro into the somatic stem cell type of interest. We present an improved highly efficient targeting system allowing genes to be integrated into a predetermined, doxycycline-inducible locus, and corresponding inducible embryonic stem cell lines to be generated rapidly. We apply this system to evaluate a key hematopoietic progenitor cell regulatory element, HoxB4, and its mammalian paralogs, whose effects have not yet been tested in this context. We show that all Hox paralog group 4 members, A4, B4, C4, and D4, have similar effects on hematopoietic stem and progenitor self-renewal in vitro, and thus classify Hox paralog group 4 as promoting self-renewal. Each paralog group 4 member both promotes proliferation and inhibits differentiation, enabling the exponential expansion of hematopoietic progenitors from the c-kit(+)/CD41(+) cell fraction of day 6 murine embryoid bodies. By evaluating a set of deletion mutants we show that sequences in addition to the homeodomain and hexapeptide motif are required for this activity. These results highlight the utility of this expression system to perform functional and structural analyses of genetic regulators of cell fate decisions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18808325      PMCID: PMC2775089          DOI: 10.1089/scd.2008.0227

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  40 in total

1.  Maintenance of functional equivalence during paralogous Hox gene evolution.

Authors:  J M Greer; J Puetz; K R Thomas; M R Capecchi
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

2.  HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.

Authors:  Jennifer Antonchuk; Guy Sauvageau; R Keith Humphries
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

3.  Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5.

Authors:  Michael Kyba; Rita C R Perlingeiro; Russell R Hoover; Chi-Wei Lu; Jonathan Pierce; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

4.  Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion.

Authors:  Unnur Thorsteinsdottir; Aline Mamo; Evert Kroon; Lori Jerome; Janet Bijl; H Jeffrey Lawrence; Keith Humphries; Guy Sauvageau
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

5.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

6.  HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.

Authors:  Michael Kyba; Rita C R Perlingeiro; George Q Daley
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

7.  A stem cell molecular signature.

Authors:  Natalia B Ivanova; John T Dimos; Christoph Schaniel; Jason A Hackney; Kateri A Moore; Ihor R Lemischka
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

8.  Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton.

Authors:  Deneen M Wellik; Mario R Capecchi
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

9.  Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development.

Authors:  T Taghon; K Thys; M De Smedt; F Weerkamp; F J T Staal; J Plum; G Leclercq
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

10.  Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells.

Authors:  Ann C M Brun; Jon Mar Björnsson; Mattias Magnusson; Nina Larsson; Per Leveén; Mats Ehinger; Eva Nilsson; Stefan Karlsson
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

View more
  42 in total

1.  Zinc finger protein ZFP57 requires its co-factor to recruit DNA methyltransferases and maintains DNA methylation imprint in embryonic stem cells via its transcriptional repression domain.

Authors:  Xiaopan Zuo; Jipo Sheng; Ho-Tak Lau; Carol M McDonald; Monica Andrade; Dana E Cullen; Fong T Bell; Michelina Iacovino; Michael Kyba; Guoliang Xu; Xiajun Li
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  ER71 directs mesodermal fate decisions during embryogenesis.

Authors:  Tara L Rasmussen; Junghun Kweon; Mackenzie A Diekmann; Fikru Belema-Bedada; Qingfeng Song; Kathy Bowlin; Xiaozhong Shi; Anwarul Ferdous; Tongbin Li; Michael Kyba; Joseph M Metzger; Naoko Koyano-Nakagawa; Daniel J Garry
Journal:  Development       Date:  2011-11       Impact factor: 6.868

3.  Effect of endoglin overexpression during embryoid body development.

Authors:  June Baik; Luciene Borges; Alessandro Magli; Tayaramma Thatava; Rita C R Perlingeiro
Journal:  Exp Hematol       Date:  2012-06-19       Impact factor: 3.084

4.  The Wnt3a/β-catenin target gene Mesogenin1 controls the segmentation clock by activating a Notch signalling program.

Authors:  Ravindra B Chalamalasetty; William C Dunty; Kristin K Biris; Rieko Ajima; Michelina Iacovino; Arica Beisaw; Lionel Feigenbaum; Deborah L Chapman; Jeong Kyo Yoon; Michael Kyba; Terry P Yamaguchi
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

5.  Sox7 is regulated by ETV2 during cardiovascular development.

Authors:  Ann N Behrens; Claudia Zierold; Xiaozhong Shi; Yi Ren; Naoko Koyano-Nakagawa; Daniel J Garry; Cindy M Martin
Journal:  Stem Cells Dev       Date:  2014-06-17       Impact factor: 3.272

6.  Characterization of an in vitro differentiation assay for pancreatic-like cell development from murine embryonic stem cells: detailed gene expression analysis.

Authors:  Chialin Chen; Jing Chai; Lipi Singh; Ching-Ying Kuo; Liang Jin; Tao Feng; Scott Marzano; Sheetal Galeni; Nan Zhang; Michelina Iacovino; Lihui Qin; Manami Hara; Roland Stein; Jonathan S Bromberg; Michael Kyba; Hsun Teresa Ku
Journal:  Assay Drug Dev Technol       Date:  2011-03-11       Impact factor: 1.738

7.  Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors.

Authors:  Radbod Darabi; Filipe N C Santos; Antonio Filareto; Weihong Pan; Ryan Koene; Michael A Rudnicki; Michael Kyba; Rita C R Perlingeiro
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

8.  OVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells.

Authors:  Ju Young Kim; Ra Ham Lee; Tae Min Kim; Dong-Wook Kim; Young-Joo Jeon; Sung-Ho Huh; Se-Yeong Oh; Michael Kyba; Hiroshi Kataoka; Kyunghee Choi; David M Ornitz; Jung-Il Chae; Changwon Park
Journal:  Blood       Date:  2014-09-29       Impact factor: 22.113

9.  HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4.

Authors:  Marilaine Fournier; Charles-Étienne Lebert-Ghali; Janetta J Bijl
Journal:  Stem Cells Dev       Date:  2015-08-12       Impact factor: 3.272

10.  Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats.

Authors:  Darko Bosnakovski; Randy S Daughters; Zhaohui Xu; Jonathan M W Slack; Michael Kyba
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.